Company Filing History:
Years Active: 2010
Title: Hughes Jean-Pierre Miel: Innovator in Selective Glucocorticoid Receptor Agonists
Introduction
Hughes Jean-Pierre Miel is a notable inventor based in Belfast, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective glucocorticoid receptor agonists. His work focuses on innovative methods for treating various inflammatory conditions and malignancies.
Latest Patents
Hughes Jean-Pierre Miel holds 1 patent for his invention titled "Selective glucocorticoid receptor agonists." This patent describes a method for treating inflammatory conditions, hematological malignancies, and preventing transplant rejection in humans and animals. The invention involves administering compounds with specific structural formulas, which have been shown to be effective in these therapeutic areas.
Career Highlights
Hughes Jean-Pierre Miel is affiliated with the University of Manchester, where he continues to advance his research in pharmacology. His work has garnered attention for its potential impact on treatment protocols for serious health conditions.
Collaborations
Hughes has collaborated with esteemed colleagues such as Stephen Alexander Barr and Michael A McKervey. These partnerships have contributed to the depth and breadth of his research endeavors.
Conclusion
Hughes Jean-Pierre Miel is a prominent figure in the field of pharmaceutical innovation, with a focus on selective glucocorticoid receptor agonists. His contributions are paving the way for new treatment options in medicine.